Cyclacel Stock Performance

CYCC
 Stock
  

USD 1.46  0.14  10.61%   

On a scale of 0 to 100, Cyclacel Pharmaceuti holds a performance score of 6. The firm shows a Beta (market volatility) of 0.9772, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Cyclacel's beta means in this case. Cyclacel Pharmaceuti returns are very sensitive to returns on the market. As the market goes up or down, Cyclacel Pharmaceuti is expected to follow. Although it is vital to follow Cyclacel Pharmaceuti historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-one technical indicators for Cyclacel Pharmaceuti, which you can use to evaluate the performance of the firm. Please makes use of Cyclacel Pharmaceuti downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to make a quick decision on whether Cyclacel Pharmaceuti price patterns will revert.
  
Cyclacel Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Cyclacel Pharmaceuti are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady fundamental indicators, Cyclacel Pharmaceuti sustained solid returns over the last few months and may actually be approaching a breakup point. ...more

Cyclacel Price Channel

Quick Ratio5.54
Fifty Two Week Low1.0100
Target High Price24.00
Fifty Two Week High5.8500
Target Low Price17.00

Cyclacel Pharmaceuti Relative Risk vs. Return Landscape

If you would invest  114.00  in Cyclacel Pharmaceuti on July 5, 2022 and sell it today you would earn a total of  32.00  from holding Cyclacel Pharmaceuti or generate 28.07% return on investment over 90 days. Cyclacel Pharmaceuti is currently generating 0.6312% in daily expected returns and assumes 7.2209% risk (volatility on return distribution) over the 90 days horizon. In different words, 62% of stocks are less volatile than Cyclacel, and 88% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Cyclacel Pharmaceuti is expected to generate 6.31 times more return on investment than the market. However, the company is 6.31 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The DOW is currently generating roughly -0.1 per unit of risk.

Cyclacel Pharmaceuti Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cyclacel Pharmaceuti's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cyclacel Pharmaceuti, and traders can use it to determine the average amount a Cyclacel Pharmaceuti's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0874

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsCYCC
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 7.22
  actual daily
 
 62 %
of total potential
 
6262
Expected Return
 0.63
  actual daily
 
 12 %
of total potential
 
1212
Risk-Adjusted Return
 0.09
  actual daily
 
 6 %
of total potential
 
66
Based on monthly moving average Cyclacel Pharmaceuti is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cyclacel Pharmaceuti by adding it to a well-diversified portfolio.

About Cyclacel Pharmaceuti Performance

To evaluate Cyclacel Pharmaceuti Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Cyclacel Pharmaceuti generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Cyclacel Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Cyclacel Pharmaceuti market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Cyclacel's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey. Cyclacel Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Things to note about Cyclacel Pharmaceuti

Checking the ongoing alerts about Cyclacel Pharmaceuti for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cyclacel Pharmaceuti help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Cyclacel Pharmaceuti Alerts

Equity Alerts and Improvement Suggestions

Cyclacel Pharmaceuti is way too risky over 90 days horizon
Cyclacel Pharmaceuti may become a speculative penny stock
Cyclacel Pharmaceuti appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 150 K. Net Loss for the year was (19.72 M) with loss before overhead, payroll, taxes, and interest of (338 K).
Cyclacel Pharmaceuti currently holds about 29.64 M in cash with (21.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from www.marketscreener.com: CYCLACEL PHARMACEUTICALS, INC. Other Events - Marketscreener.com
Continue to Trending Equities. Note that the Cyclacel Pharmaceuti information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Cyclacel Stock analysis

When running Cyclacel Pharmaceuti price analysis, check to measure Cyclacel Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuti is operating at the current time. Most of Cyclacel Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cyclacel Pharmaceuti's price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Cyclacel Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuti. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cyclacel Pharmaceuti is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuti's market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Cyclacel Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.